Navigation Links
ConvaTec Announces 2013 Second Quarter Earnings Call
Date:8/23/2013

LUXEMBOURG, Aug. 23, 2013 /PRNewswire/ -- ConvaTec today announced that it will report its 2013 second quarter earnings on Wednesday, August 28, 2013. Ken Berger, CEO, and John Cannon, acting CFO, will host an analyst and investor call at 9:00 AM ET live via telephone.

To participate in the conference call within the U.S. and Canada, dial (877) 366-0267.

To participate in the conference call outside the U.S. and Canada, dial (760) 666-3086.

The conference ID is 35722179.

Participants should dial in 10 minutes prior to the start of the call. The Company's 2013 Second Quarter Report will be available on the Company's website prior to the call under the Investor Community at www.convateccorporate.com.

For more information, please contact investorrelations@convatec.com.

About ConvaTec
ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key focus areas – Ostomy Care, Wound Therapeutics, Continence and Critical Care, and Infusion Devices – ConvaTec products support healthcare professionals from the hospital to the community health setting. For more information, please visit www.convatec.com.


'/>"/>
SOURCE ConvaTec
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. ConvaTec Announces 2013 First Quarter Earnings Call
2. ConvaTec Announces 2012 Year-End Earnings Call
3. ConvaTec, A Leader In Antimicrobial Dressings And Infection Management, To Host Live International Webcast On Minimizing Risk Of Wound Infections
4. ConvaTec To Acquire Intermittent Catheter Provider
5. ConvaTec Introduces Enhanced Flexi-Seal® SIGNAL® FMS
6. ConvaTec Announces Acquisition of AbViser Medical, LLC
7. ConvaTec Donates $10,000 To AAWC Global Volunteers Program Through SAWC Walk For Wellness
8. Sam Solakyan, CEO of Vital Imaging Announces purchase of cutting edge equipment
9. Yew Bio-Pharm Group Announces Coverage by S&P Capital IQ
10. Cellular Biomedicine Group Announces Completion of Patient Enrollment for Phase I Clinical Trial for Liver Cancer
11. Avanir Pharmaceuticals Announces Publication of PRISM Pseudobulbar Affect Registry Findings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... SPRING, Md. , Aug. 29, 2014  United ... that the U.S. District Court for the District of ... its favor in the company,s case against Sandoz, Inc. ... Judge Peter Sheridan ruled that U.S. Patent ... Inc., and enjoined Sandoz from marketing its generic product ...
(Date:8/29/2014)... August 29, 2014 According ... Product & Services (Equipment, Reagent, Primer, Probe, Custom ... PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) - ... global Oligonucleotide Synthesis Market is expected to reach ... 2014, growing at a CAGR of 9.8% from ...
(Date:8/29/2014)... 2014  Unilife Corporation ("Unilife" or "Company") (NASDAQ: ... intends to release its financial results for the fiscal ... after market trading ends on Tuesday, September 9, 2014. ... for 4:30 p.m. U.S. EDT on Tuesday, September 9, ... review the Company,s financial results, commercial partnerships, and future ...
Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2
... certain mutations enable specific cells in the,retina to ... suggests deliberate,genetic manipulations might coax an injured brain ... Investigators at St.,Jude Children,s Research Hospital have ... cancer retinoblastoma, disproving a long-standing principle of,nerve growth ...
... Oct. 18 CEL-SCI CORPORATION,(Amex: CVM ) ... is a featured presenter at the International Society ... Mr. Kersten will present on the "New Realities ... p.m. (Eastern Daylight,Time). In April 2007, CEL-SCI ...
Cached Medicine Technology:St. Jude Identifies the Specific Cell That Causes Eye Cancer, Disproving Long-Held Theory 2St. Jude Identifies the Specific Cell That Causes Eye Cancer, Disproving Long-Held Theory 3CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase 2
(Date:8/29/2014)... Prostate cancer patients lacking knowledge about the disease have ... worse quality of care and long-term results, new research ... median age of 63. All were newly diagnosed with ... was associated with greater difficulty deciding which treatment to ... effective, the study found. "For prostate cancer, there ...
(Date:8/29/2014)... University School of Medicine have identified one way the ... insight that could lead to new therapies, in ... Host & Microbe . , In work performed at ... the researchers developed a detailed map of how a ... that takes signaling molecules in and out of the ...
(Date:8/29/2014)... PA (PRWEB) August 29, 2014 After ... from Harrisburg, Pa., had to have breast reconstruction. She ... be sub-par, so she decided that there needed to ... better look for a woman or man who needs ... as well as promotes confidence and peace of mind. ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Evolutions Medical ... Barbara in the Santa Barbara News-Press Readers’ Choice 2014 ... the Readers’ Choice poll as Best Medical Spa. The ... reads the following about Evolutions Medical Spa recognition: , ... it is recognized as a top-notch, cutting-edge medical spa ...
(Date:8/29/2014)... 2014 RBS Reputation Management has brought a ... The service is to help those individuals and organizations that ... Scam Book. The service would push down the ranking of ... complaints fully invisible on Google. , RBS Reputation Management ... being asked how company can provide guarantee of results with ...
Breaking Medicine News(10 mins):Health News:Faced With Prostate Cancer, It Helps to Know the Enemy 2Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 2Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 3Health News:RBS Reputation Management Announces a New Online Reputation Management Service 2
... conducted by the University of Texas, and the ... on thinking, memory and other important tasks. ... that chewing gum// targeted memory," Andrew Scholey of the ... words and performed better in tests on working memory." ...
... An innovative way to predict risk of surgery. Lens ... predict when complications are developing after coronary bypass surgery. ... tend to re-block, risking heart attack and requiring further ... could be detected at an early stage, it's possible ...
... smallpox, which kills about 30% of its victims and leaves ... of exposure can protect against illness. A French drug company ... smallpox vaccine and the United States said it would accept ... disease. // ,The UnitedStates has been working to gather ...
... tamoxifen does not damage the brains of elderly ... such treatment, recent study has revealed. According to ... brain to oestrogen, which has been linked with ... researchers used proton magnetic resonance spectroscopy to determine ...
... Plavix (clopidogrel bisulfate) received US Food and Drug Administration ... acute coronary syndrome are at high risk for heart ... disease-related chest pain. About 1.1 to 1.4 million Americans ... was first approved in 1997 for patients with a ...
... Americans are opting for dental implants to replace problem teeth. ... //the traditional solution to the problem is to go for ... inserted into the mouth. But implants teeth inserted into the ... according to the American Dental Association's latest survey. ...
Cached Medicine News:
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and ...
The upper body blanket covers the upper torso, arms, neck, and head of the patient....
The Electri-Cool® II is the premier choice when it comes to localized cold therapy systems. system offers the widest variety of application-specific pads and wraps, for your convenience....
Complete Cataract Competence , OPMI VISU 140 is compact, good and economical. It's everything a cataract specialist needs today....
Medicine Products: